Traphagen Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Sell
9,611
-40
-0.4% -$8.87K 0.17% 52
2025
Q4
$2.21M Buy
9,651
+15
+0.2% +$3.42K 0.18% 46
2025
Q3
$2.23M Buy
9,636
+10
+0.1% +$2.04K 0.19% 44
2025
Q2
$1.79M Sell
9,626
-9
-0.1% -$1.67K 0.17% 50
2025
Q1
$2.02M Sell
9,635
-64
-0.7% -$12.4K 0.21% 45
2024
Q4
$1.72M Buy
9,699
+5
+0.1% +$919 0.18% 46
2024
Q3
$1.91M Sell
9,694
-69
-0.7% -$12.9K 0.19% 41
2024
Q2
$1.67M Sell
9,763
-60
-0.6% -$9.94K 0.18% 48
2024
Q1
$1.79M Buy
9,823
+98
+1% +$16.9K 0.19% 47
2023
Q4
$1.51M Sell
9,725
-103
-1% -$15K 0.18% 48
2023
Q3
$1.47M Buy
9,828
+5
+0.1% +$734 0.19% 41
2023
Q2
$1.32M Buy
9,823
+5,071
+107% +$744K 0.17% 50
2023
Q1
$757K Buy
4,752
+287
+6% +$43.9K 0.11% 66
2022
Q4
$722K Buy
4,465
+1,032
+30% +$158K 0.11% 64
2022
Q3
$799K Hold
3,433
0.15% 49
2022
Q2
$826K Hold
3,433
0.15% 48
2022
Q1
$858K Sell
3,433
-2,499
-42% -$363K 0.14% 48
2021
Q4
$803K Buy
5,932
+63
+1% +$7.44K 0.13% 57
2021
Q3
$633K Buy
5,869
+40
+0.7% +$4.57K 0.11% 58
2021
Q2
$657K Buy
5,829
+288
+5% +$32.4K 0.11% 60
2021
Q1
$600K Buy
5,541
+4
+0.1% +$428 0.11% 66
2020
Q4
$593K Sell
5,537
-58
-1% -$5.57K 0.11% 69
2020
Q3
$490K Buy
5,595
+392
+8% +$36.9K 0.1% 70
2020
Q2
$511K Buy
5,203
+51
+1% +$4.49K 0.12% 68
2020
Q1
$393K Buy
5,152
+95
+2% +$8.09K 0.11% 78
2019
Q4
$448K Hold
5,057
0.11% 76
2019
Q3
$383K Sell
5,057
-152
-3% -$10.4K 0.1% 77
2019
Q2
$379K Buy
5,209
+2
+0% +$157 0.1% 78
2019
Q1
$420K Buy
+5,207
New +$426K 0.12% 65

Other funds holding ABBV